Top

Published in:

01-01-2023 | Nevi | Case report

Elexacaftor/ivacaftor/tezacaftor

First report of eruptive melanocytic naevi: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

A 29-year-old woman developed eruptive melanocytic naevi during treatment with elexacaftor/ivacaftor/tezacaftor for cystic fibrosis (CF) [dosage and route not stated]. …

Atkinson M, et al. Eruptive melanocytic naevi following initiation of elexacaftor/ivacaftor/tezacaftor for cystic fibrosis. Journal of Cystic Fibrosis 21: 1070-1073, No. 6, Nov 2022. Available from: URL: http://doi.org/10.1016/j.jcf.2022.06.004

Title: Elexacaftor/ivacaftor/tezacaftor
First report of eruptive melanocytic naevi: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Nevi
Cystic Fibrosis
Cystic Fibrosis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30725-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Elexacaftor/ivacaftor/tezacaftor

First report of eruptive melanocytic naevi: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Clozapine

Anakinra/betamethasone/methylprednisolone

Bamlanivimab

Alendronic-acid

Tamoxifen

Sorafenib